China Pharma Holdings (CPHI)

$1.90 +0.06 (3.42%)
Market Cap 6.00M
Revenue (ttm) 4.53M
Net Income (ttm) -4.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -104.64%
Debt to Equity Ratio 0.33
Volume 28,400
Avg Vol 105,378
Day's Range N/A - N/A
Shares Out 3.26M
Stochastic %K 89%
Beta 0.79
Analysts Strong Buy
Price Target $4.50

Company Profile

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylg...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 86 89 8668 11730
Fax: 86 89 8668 19024
Address:
No. 17, Jinpan Road, Second Floor, Haikou, China
Jmoney914
Jmoney914 Jul. 11 at 8:57 PM
$CPHI
0 · Reply
Rampart1
Rampart1 Jul. 11 at 5:51 PM
$CPHI see on on the moon. over 3 IMHO.
0 · Reply
Rampart1
Rampart1 Jul. 11 at 3:32 PM
$CPHI hmm.
0 · Reply
Elaine_Shrimp
Elaine_Shrimp Jul. 11 at 2:33 PM
$CPHI chart intriguing... Mark 👀
1 · Reply
TCEnterprises
TCEnterprises Jul. 11 at 1:36 PM
$ABVE $CPHI $SGN
0 · Reply
Ultra_Calls
Ultra_Calls Jul. 11 at 1:34 PM
$CPHI Should be $3.50+ why is this so cheap under $2 right now? Could run like $ABVE // $SGN
0 · Reply
onestudy
onestudy Jul. 11 at 12:25 PM
$CPHI CPHI CEO loaned $1.15M to the company (confirmed in 2025 10-Q). CPHI raises capital with their own money. 100% conviction.
0 · Reply
onestudy
onestudy Jul. 10 at 1:13 PM
$CPHI CPHI key catalyst triggered. NMPA must respond within 40 days. Only 1.2M float with 64% insider ownership.
0 · Reply
onestudy
onestudy Jul. 9 at 6:45 PM
$CPHI 📢 Chinese Gov. Awards CPHI A New Drug Contract (Guangxi, June 2025) Boom! $CPHI (Hainan Helpson Medical & Biotechnology Co., Ltd.) has been officially awarded a new provincial drug contract in Guangxi, China for its bone drug, Disodium Clodronate Phosphate Injection. 💉 Contract Details: Dosage Forms: 1ml:50mg and 2ml:100mg Listed Prices: ¥9.71 and ¥12.13 Approval Date: June 24, 2025 Listed by: Chinese government procurement platform (Original Chinese-language screenshot attached for double-checking)
0 · Reply
onestudy
onestudy Jul. 9 at 2:21 PM
$CPHI Is CPHI a Chinese company? I think it is. In the Stocktwitss world, Chinese companies can make you rich, very rich....like10x. Money doesn’t have pride or prejudice. I like American companies, I like Chinese companies, and I love money.
0 · Reply
Latest News on CPHI
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

Apr 4, 2025, 4:05 PM EDT - 3 months ago

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

Dec 18, 2024, 8:30 AM EST - 7 months ago

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

China Pharma Announces the Entry of "At-The-Market" Equity Offering

Dec 13, 2024, 8:00 AM EST - 7 months ago

China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

Aug 19, 2024, 8:00 AM EDT - 11 months ago

China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

Feb 23, 2024, 4:05 PM EST - 1 year ago

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

Nov 29, 2023, 8:00 AM EST - 1 year ago

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

Aug 9, 2023, 8:30 AM EDT - 2 years ago

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

Dec 28, 2022, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

Dec 15, 2022, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

Dec 5, 2022, 8:00 AM EST - 2 years ago

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

Dec 2, 2022, 4:10 PM EST - 2 years ago

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

Oct 1, 2022, 10:05 PM EDT - 3 years ago

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

Jul 18, 2022, 8:00 AM EDT - 3 years ago

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

Mar 31, 2022, 8:00 AM EDT - 3 years ago

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

Nov 12, 2021, 4:30 PM EST - 3 years ago

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

Aug 13, 2021, 4:30 PM EDT - 4 years ago

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

Aug 5, 2021, 9:00 AM EDT - 4 years ago

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

China Pharma to Launch Highly Purified NMN+PQQ Product

Jun 9, 2021, 8:00 AM EDT - 4 years ago

China Pharma to Launch Highly Purified NMN+PQQ Product

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

May 14, 2021, 4:30 PM EDT - 4 years ago

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

Apr 19, 2021, 8:30 AM EDT - 4 years ago

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

Mar 26, 2021, 5:00 PM EDT - 4 years ago

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript

Mar 31, 2020, 9:36 AM EDT - 5 years ago

China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript

China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript

Aug 15, 2019, 1:13 PM EDT - 6 years ago

China Pharma's (CPHI) CEO Zhilin Li on Q2 2019 Results - Earnings Call Transcript

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript

May 15, 2019, 10:31 AM EDT - 6 years ago

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript

Mar 29, 2019, 1:16 PM EDT - 6 years ago

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q4 2018 Results - Earnings Call Transcript

Jmoney914
Jmoney914 Jul. 11 at 8:57 PM
$CPHI
0 · Reply
Rampart1
Rampart1 Jul. 11 at 5:51 PM
$CPHI see on on the moon. over 3 IMHO.
0 · Reply
Rampart1
Rampart1 Jul. 11 at 3:32 PM
$CPHI hmm.
0 · Reply
Elaine_Shrimp
Elaine_Shrimp Jul. 11 at 2:33 PM
$CPHI chart intriguing... Mark 👀
1 · Reply
TCEnterprises
TCEnterprises Jul. 11 at 1:36 PM
$ABVE $CPHI $SGN
0 · Reply
Ultra_Calls
Ultra_Calls Jul. 11 at 1:34 PM
$CPHI Should be $3.50+ why is this so cheap under $2 right now? Could run like $ABVE // $SGN
0 · Reply
onestudy
onestudy Jul. 11 at 12:25 PM
$CPHI CPHI CEO loaned $1.15M to the company (confirmed in 2025 10-Q). CPHI raises capital with their own money. 100% conviction.
0 · Reply
onestudy
onestudy Jul. 10 at 1:13 PM
$CPHI CPHI key catalyst triggered. NMPA must respond within 40 days. Only 1.2M float with 64% insider ownership.
0 · Reply
onestudy
onestudy Jul. 9 at 6:45 PM
$CPHI 📢 Chinese Gov. Awards CPHI A New Drug Contract (Guangxi, June 2025) Boom! $CPHI (Hainan Helpson Medical & Biotechnology Co., Ltd.) has been officially awarded a new provincial drug contract in Guangxi, China for its bone drug, Disodium Clodronate Phosphate Injection. 💉 Contract Details: Dosage Forms: 1ml:50mg and 2ml:100mg Listed Prices: ¥9.71 and ¥12.13 Approval Date: June 24, 2025 Listed by: Chinese government procurement platform (Original Chinese-language screenshot attached for double-checking)
0 · Reply
onestudy
onestudy Jul. 9 at 2:21 PM
$CPHI Is CPHI a Chinese company? I think it is. In the Stocktwitss world, Chinese companies can make you rich, very rich....like10x. Money doesn’t have pride or prejudice. I like American companies, I like Chinese companies, and I love money.
0 · Reply
I_Need_A_Winner
I_Need_A_Winner Jul. 8 at 10:39 PM
$CPHI agreed but it is a chinese stock. notorious bullshit artists to the nth degree. that said….love my 1.50 avg
0 · Reply
Ronin232
Ronin232 Jul. 8 at 4:54 PM
$CPHI wonder when we’ll see the fruition of these contract deals
0 · Reply
onestudy
onestudy Jul. 8 at 3:46 PM
$CPHI Another big win for $CPHI! The company’s Omeprazole Sodium for Injection (40mg) secured a government procurement contract in Shanxi Province on June 24, 2025.
0 · Reply
JMJTrading
JMJTrading Jul. 8 at 2:40 PM
$PET - A steady rise day after day, higher closes and higher lows - correction play here. In this for $1 plus. When this hits that I will add to $CHSN and $CPHI
0 · Reply
onestudy
onestudy Jul. 8 at 1:27 PM
$CPHI New drug on track for NMPA registration in Q3 2025. We’re almost there. It's already July and the PR is long overdue.
0 · Reply
Rampart1
Rampart1 Jul. 7 at 9:13 PM
$CPHI lol. Algos. 😂
0 · Reply
onestudy
onestudy Jul. 7 at 5:28 PM
$CPHI 💥 Boom! On a public object storage bucket hosted on Alibaba Cloud OSS (Object Storage Service)—commonly used by Chinese government agencies—I found that $CPHI has submitted an official file for its drug to win more government contracts, with approval valid until 2025/8/16! 🚀🚀(I will attach the original Chinese version for double-checking.)
1 · Reply
maestro_of_the_markets
maestro_of_the_markets Jul. 7 at 4:00 PM
$CPHI stop being victims here and request the CEO fire her own ass ASAP for total incompetence! 😉
0 · Reply
Rampart1
Rampart1 Jul. 7 at 1:41 PM
$CPHI curling up. looks great.
0 · Reply
onestudy
onestudy Jul. 3 at 1:18 PM
$CPHI 📢 Wins New Drug Contract in China! CPHI has been awarded a new contract for its Compound Glycyrrhizin Injection in Guangxi Province, announced on June 24, 2025. I will include the original screenshot of the contract in Chinese for double-check. 💊 Drug Type: Anti-inflammatory & liver-protective 📍 Province: Guangxi, China 💰 Price: ¥10.10 🏭 Manufacturer: CPHI Compound Glycyrrhizin Injection is commonly used in China to treat chronic liver conditions, hepatitis, and allergic reactions. CPHI is making real sales with strong and ongoing government support. Let's go!
1 · Reply
I_Need_A_Winner
I_Need_A_Winner Jul. 3 at 12:42 AM
$CPHI agreed. BS trading action. wash sales to then cover? makes no sense. oh well, still waiting for $5+ here soon once commies decide to run it
1 · Reply
Elaine_Shrimp
Elaine_Shrimp Jul. 2 at 9:17 PM
$CPHI 👀 weird
0 · Reply